{"transactions":[{"id":700528,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:34:20.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest as follows: 1/3 on July 28, 2027, with the remaining restricted stock vesting in 8 equal quarterly installments beginning October 28, 2027."}],"balance_after":237203,"source":{"system":"sec-edgar","filing":"0001437749-26-025083","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926025083/rdgdoc.xml","form_type":"4"}},{"id":826855,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T18:00:59.000Z","date":"2026-03-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Issuer's Third Amended Combined Disclosure Statement and Joint Chapter 11 Plan of Reorganization of Zynex, Inc. and Its Affiliated Debtors Pursuant to Chapter 11 of the Bankruptcy Code (the \"Plan\") which was confirmed by the United States Bankruptcy Court for the Southern District of Texas on March 19, 2026 and became effective on March 26, 2026, all outstanding shares of the Issuer's common stock (including shares of common stock issuable under equity awards granted under the Issuer's equity incentive plans) and all other options, warrants and other rights with respect thereto, have been cancelled for no consideration and of no further force and effect with no recovery under the Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001566240-26-000002","document":"form4-03272026_100355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/846475/000156624026000002/form4-03272026_100355.xml","form_type":"4"}},{"id":826854,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2026-03-27T18:00:59.000Z","date":"2026-03-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Issuer's Third Amended Combined Disclosure Statement and Joint Chapter 11 Plan of Reorganization of Zynex, Inc. and Its Affiliated Debtors Pursuant to Chapter 11 of the Bankruptcy Code (the \"Plan\") which was confirmed by the United States Bankruptcy Court for the Southern District of Texas on March 19, 2026 and became effective on March 26, 2026, all outstanding shares of the Issuer's common stock (including shares of common stock issuable under equity awards granted under the Issuer's equity incentive plans) and all other options, warrants and other rights with respect thereto, have been cancelled for no consideration and of no further force and effect with no recovery under the Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001566240-26-000002","document":"form4-03272026_100355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000156624026000002/form4-03272026_100355.xml","form_type":"4"}},{"id":1021994,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:11:20.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027."}],"balance_after":207203,"source":{"system":"sec-edgar","filing":"0001437749-25-030642","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925030642/rdgdoc.xml","form_type":"4"}},{"id":1021993,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:11:20.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":31446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus."}],"balance_after":184703,"source":{"system":"sec-edgar","filing":"0001437749-25-030642","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925030642/rdgdoc.xml","form_type":"4"}},{"id":1116044,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-10T19:04:30.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":1.5,"value":99999.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025."}],"balance_after":153257,"source":{"system":"sec-edgar","filing":"0001437749-25-019956","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925019956/rdgdoc.xml","form_type":"4"}},{"id":1146400,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2025-05-16T18:00:09.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001415889-25-013482","document":"form4-05162025_060505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000141588925013482/form4-05162025_060505.xml","form_type":"4"}},{"id":1235328,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-03T18:35:04.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.3,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 28, 2025, Joshua R. Disbrow, purchased a total of 15,000 shares of common stock in multiple open market transaction at prices per share ranging from $1.29 to $1.30, with a weighted average price of approximately $1.30 per share. Mr. Disbrow undertakes to provide to AYTU BIOPHARMA, INC., any security holder of AYTU BIOPHARMA, INC., or the staff of the United States Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 28, 2025, Joshua R. Disbrow, purchased a total of 15,000 shares of common stock in multiple open market transaction at prices per share ranging from $1.29 to $1.30, with a weighted average price of approximately $1.30 per share. Mr. Disbrow undertakes to provide to AYTU BIOPHARMA, INC., any security holder of AYTU BIOPHARMA, INC., or the staff of the United States Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":86591,"source":{"system":"sec-edgar","filing":"0001437749-25-005873","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925005873/rdgdoc.xml","form_type":"4"}},{"id":1371038,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-09T00:55:50.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025."}],"balance_after":38000,"derivative":{"exercise_price":1.84,"expiration_date":"2034-11-06","underlying":"Common Shares","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000912282-24-000758","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228224000758/form4.xml","form_type":"4"}},{"id":1446762,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T18:25:26.000Z","date":"2024-07-29","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":8.319,"value":58233.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 29, 2024, Joshua Disbrow, purchased 7,000 shares of common stock in an open market transaction at a price per share equal to $8.319, increasing Mr. Disbrow's beneficially owned shares to 72,000 shares."}],"balance_after":72000,"source":{"system":"sec-edgar","filing":"0001415889-24-020376","document":"form4-07302024_100722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000141588924020376/form4-07302024_100722.xml","form_type":"4"}},{"id":1512909,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2024-05-17T17:00:14.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":22587,"source":{"system":"sec-edgar","filing":"0001415889-24-013558","document":"form4-05172024_050503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000141588924013558/form4-05172024_050503.xml","form_type":"4"}},{"id":1807065,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-15T23:34:57.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024."}],"balance_after":35000,"derivative":{"exercise_price":1.73,"expiration_date":"2033-08-12","underlying":"Common Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000912282-23-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228223000299/form4.xml","form_type":"4"}},{"id":1853429,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2023-06-16T17:30:25.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":22171,"source":{"system":"sec-edgar","filing":"0001104659-23-072360","document":"tm2319010-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000110465923072360/tm2319010-2_4seq1.xml","form_type":"4"}},{"id":1853986,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-06-15T17:52:53.000Z","date":"2023-06-14","kind":"purchase","planned":false,"acquired":true,"shares":14000,"price":1.8628,"value":26079.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported in Column 4 above is an average weighted price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023."}],"balance_after":71591,"source":{"system":"sec-edgar","filing":"0000912282-23-000133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228223000133/form4.xml","form_type":"4"}},{"id":2076618,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-23T22:27:26.000Z","date":"2022-12-20","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 80,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021.  The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 80,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021.  The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."}],"balance_after":1151877,"source":{"system":"sec-edgar","filing":"0001567619-22-021999","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761922021999/doc1.xml","form_type":"4"}},{"id":2078534,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-21T14:17:07.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":112371,"price":0.2229,"value":25047.4959,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.213 to $0.23, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":1231877,"source":{"system":"sec-edgar","filing":"0001567619-22-021900","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761922021900/doc1.xml","form_type":"4"}},{"id":2103191,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-28T21:30:31.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":222000,"price":0.237,"value":52614.0,"ownership":{"direct":true},"balance_after":1119506,"source":{"system":"sec-edgar","filing":"0001567619-22-020922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761922020922/doc1.xml","form_type":"4/A","original_submission_date":"2022-11-21"}},{"id":2108263,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-21T14:30:25.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":222000,"price":0.237,"value":52614.0,"ownership":{"direct":true},"balance_after":1119506,"source":{"system":"sec-edgar","filing":"0001654954-22-015599","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495422015599/section16.xml","form_type":"4"}},{"id":2248349,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2022-06-02T17:19:32.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":24208,"source":{"system":"sec-edgar","filing":"0001104659-22-067713","document":"tm2217566-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000110465922067713/tm2217566-2_4seq1.xml","form_type":"4"}},{"id":2631181,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2021-07-19T18:55:50.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":23751,"source":{"system":"sec-edgar","filing":"0001104659-21-093611","document":"tm2122577-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000110465921093611/tm2122577-3_4seq1.xml","form_type":"4"}},{"id":2746694,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-16T20:49:57.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). (4) At the Compensation Committee's discretion based on the Company achieving certain revenue milestones and the successful integration of future acquisitions. The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). (4) At the Compensation Committee's discretion based on the Company achieving certain revenue milestones and the successful integration of future acquisitions. The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."}],"balance_after":897506,"source":{"system":"sec-edgar","filing":"0001567619-21-008228","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761921008228/doc1.xml","form_type":"4"}},{"id":3073676,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2020-07-30T21:34:12.000Z","date":"2020-07-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of three years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-20-088595","document":"tm2026157d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/846475/000110465920088595/tm2026157d2_4.xml","form_type":"4"}},{"id":3073675,"issuer":{"id":55698,"kind":"organization","name":"ZYNEX INC","symbol":"ZYXI"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Restricted Stock Award)","published_at":"2020-07-30T21:34:12.000Z","date":"2020-07-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the \"Plan\") pursuant to which the 10,000 shares vest equally, on a quarterly basis, over a period of two years beginning one quarter from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents restricted stock awards under the Plan, which have not vested."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-20-088595","document":"tm2026157d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/846475/000110465920088595/tm2026157d2_4.xml","form_type":"4"}},{"id":3111498,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2020-06-12T21:44:15.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2.\t25% vests on June 7, 2021, with an additional 6.25% of the total shares vesting quarterly thereafter, subject to continued service through each vesting date until June 7, 2024."}],"balance_after":100275,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001654954-20-006583","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495420006583/section16.xml","form_type":"4"}},{"id":3111497,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2020-06-12T21:44:15.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1.\tThese are restricted shares. 25% vests on June 7, 2021, with an additional 6.25% of the total shares vesting quarterly thereafter, subject to continued service through each vesting date until June 7, 2024"}],"balance_after":975048,"source":{"system":"sec-edgar","filing":"0001654954-20-006583","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495420006583/section16.xml","form_type":"4"}},{"id":3335027,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-19T20:10:33.000Z","date":"2019-12-19","kind":"purchase","acquired":true,"shares":5000,"price":0.8908,"value":4454.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 453,475 restricted shares."}],"balance_after":525048,"source":{"system":"sec-edgar","filing":"0001654954-19-014096","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495419014096/section16.xml","form_type":"4"}},{"id":3335026,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-19T20:10:33.000Z","date":"2019-12-19","kind":"purchase","acquired":true,"shares":50000,"price":0.8874,"value":44370.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 453,475 restricted shares."}],"balance_after":520048,"source":{"system":"sec-edgar","filing":"0001654954-19-014096","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495419014096/section16.xml","form_type":"4"}},{"id":3751579,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2018-11-28T02:40:52.000Z","date":"2018-11-26","kind":"purchase","acquired":true,"shares":5000,"price":0.1,"value":500.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":72,"exercise_date":"2018-11-26","expiration_date":"2022-08-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-18-016611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018016611/ownership.xml","form_type":"4"}},{"id":3782190,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-10-26T23:49:55.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":445500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 7,975 post-split restricted shares previously issued."}],"balance_after":470048,"source":{"system":"sec-edgar","filing":"0001213900-18-014532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018014532/ownership.xml","form_type":"4"}},{"id":4007670,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2018-03-07T21:39:33.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":226105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Warrants were issued as part of units with the shares of common stock."}],"balance_after":226105,"derivative":{"exercise_price":0.54,"exercise_date":"2018-03-06","expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":226105},"source":{"system":"sec-edgar","filing":"0001213900-18-002658","document":"f4030618joshdisbrow_aytubio.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018002658/f4030618joshdisbrow_aytubio.xml","form_type":"4"}},{"id":4007669,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:39:33.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":226105,"price":0.45,"value":101747.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 159,500 restricted shares."}],"balance_after":490949,"source":{"system":"sec-edgar","filing":"0001213900-18-002658","document":"f4030618joshdisbrow_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018002658/f4030618joshdisbrow_aytubio.xml","form_type":"4"}},{"id":4167257,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-11-10T00:02:24.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 9,500 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":264844,"source":{"system":"sec-edgar","filing":"0001213900-17-011711","document":"f4110717joshdisbrow_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390017011711/f4110717joshdisbrow_aytubio.xml","form_type":"4"}},{"id":4227361,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:55:21.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on July 7, 2017, 33.3% vests on July 7, 2018 and 33.4% on July 7, 2019, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":60000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4227360,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:55:21.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vests on November 11, 2016, 33.3% vests on November 11, 2017 and 33.4% vests on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":50000,"derivative":{"exercise_price":0.82,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4227359,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:55:21.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on July 7, 2017, 33.3% vests on July 7, 2018 and 33.4% on July 7, 2019, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4227358,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:55:21.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vests on November 11, 2016, 33.3% vests on November 11, 2017 and 33.4% vests on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4227357,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-08-22T23:55:21.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":2500000,"price":0.18,"value":450000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.18,"exercise_date":"2017-08-15","expiration_date":"2022-08-15","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4227356,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-22T23:55:21.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":1666667,"price":0.15,"value":250000.05,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 190,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":2296861,"source":{"system":"sec-edgar","filing":"0001638599-17-000784","document":"doc4_4897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000784/doc4_4897.xml","form_type":"4"}},{"id":4379271,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:18:12.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on July 7, 2017, 33.3% vests on July 7, 2018 and 33.4% on July 7, 2019, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":60000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000289","document":"doc4_4621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000289/doc4_4621.xml","form_type":"4"}},{"id":4379270,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:18:12.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vests on November 11, 2016, 33.3% vests on November 11, 2017 and 33.4% vests on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":50000,"derivative":{"exercise_price":0.82,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000289","document":"doc4_4621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000289/doc4_4621.xml","form_type":"4"}},{"id":4379269,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:18:12.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on July 7, 2017, 33.3% vests on July 7, 2018 and 33.4% on July 7, 2019, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000289","document":"doc4_4621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000289/doc4_4621.xml","form_type":"4"}},{"id":4379268,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:18:12.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vests on November 11, 2016, 33.3% vests on November 11, 2017 and 33.4% vests on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000289","document":"doc4_4621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000289/doc4_4621.xml","form_type":"4"}},{"id":4413314,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warran to Purchase Common Stock","published_at":"2017-03-01T23:41:24.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2016-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001638599-17-000229","document":"doc4_4570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000229/doc4_4570.xml","form_type":"4"}},{"id":4413313,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-03-01T23:41:24.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":166666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001638599-17-000229","document":"doc4_4570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000229/doc4_4570.xml","form_type":"4"}},{"id":4413312,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-01T23:41:24.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":187500,"price":0.75,"value":140625.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 190,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":630194,"source":{"system":"sec-edgar","filing":"0001638599-17-000229","document":"doc4_4570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000229/doc4_4570.xml","form_type":"4"}},{"id":4516682,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2016-12-19T13:32:59.000Z","date":"2016-12-16","kind":"purchase","acquired":true,"shares":28924,"price":0.07,"value":2024.68,"ownership":{"direct":true},"balance_after":28924,"derivative":{"exercise_price":6,"exercise_date":"2016-12-16","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":28924},"source":{"system":"sec-edgar","filing":"0001638599-16-001707","document":"doc4_4409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001707/doc4_4409.xml","form_type":"4"}},{"id":4566389,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2016-11-04T20:57:33.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."}],"balance_after":166666,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001638599-16-001506","document":"doc4_4275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001506/doc4_4275.xml","form_type":"4"}},{"id":4566388,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27712,"kind":"person","name":"Disbrow Joshua R.","position":1,"cik":"0001566240","reported_name":"Disbrow Joshua R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-04T20:57:33.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":166666,"price":1.5,"value":249999.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 190,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":442694,"source":{"system":"sec-edgar","filing":"0001638599-16-001506","document":"doc4_4275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001506/doc4_4275.xml","form_type":"4"}}]}